Als nächstes


Gold Shield Group TV Commercial, 'Type-2 Diabetes Medication Side Effects'

Published Im

Gold Shield Group announces that various medications such as Invokana, Invokamet, Jardiance and Farxiga are linked to an increased risk of toe, leg and foot amputations. Type-2 Diabetics who suffered serious side effects after taking these medications are encouraged to call and file a claim.

Zeig mehr
0 Bemerkungen sort Sortiere nach

Facebook Kommentare